ArtNr |
HY-13271A-200mg |
Hersteller |
MedChem Express
|
CAS-Nr. |
1252003-15-8 |
Menge |
200 mg |
Quantity options |
100 mg
10mM/1mL
10 mg
200 mg
50 mg
5 mg
|
Kategorie |
|
Typ |
Inhibitors |
Clon |
N/A |
Specific against |
other |
Purity |
98.37 |
Formula |
C20H21N3O2 |
Citations |
Acta Pharm Sin B. 20 May 2022.<br/>Aging. 2021 Mar 19;13(7):9820-9837.<br/>Am J Pathol. 2020 Dec;190(12):2376-2386.<br/>Antioxidants (Basel). 2022 Apr 7;11(4):732.<br/>Antioxidants. 2020 Jul 9;9(7):599.<br/>Biochim Biophys Acta Mol Cell Res. 2020 May;1867(5):118676.<br/>bioRxiv. 2021 Feb 25.<br/>BMC Biol. 2018 Oct 18;16(1):116.<br/>J Dermatol Sci. 2022 May 17;S0923-1811(22)00125-6.<br/>J Med Chem. 2023 Nov 16.<br/>J Mol Neurosci. 2024 Mar 13.<br/>J Nutr. 2020 Jul 1;150(7):1790-1798.<br/>Medical Science, University of Toronto. 2017 Nov.<br/>Mol Cancer Res. 2014 May;12(5):681-93.<br/>Mol Cancer Res. 2022 Mar 4;molcanres.0923.2021.<br/>Neurotherapeutics. 2023 Jun 2.<br/>NPJ Precis Oncol. 2024 Mar 7;8(1):66.<br/>Patent. US20180263995A1.<br/>Atherosclerosis. 2021 Jan;317:1-9.<br/>Cell Death Dis. 2022 Oct 21;13(10):888.<br/>Front Pharmacol. 2018 Feb 1;9:34.<br/>Hum Mol Genet. 2022 Jan 12;ddac008.<br/>Neurotherapeutics. 2023 Jun 2.<br/>PLoS Pathog. 2021 Sep 20;17(9):e1009940.<br/>[1]Kyle V. Butler et al. Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A J. Am. Chem. Soc., 2010, 132 (31), pp 10842-10846<br/>[2]de Zoeten EF, et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells. Mol Cell Biol. 2011 May;31(10):2066-78.<br/>[3]Di Fulvio S, et al. Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation. PLoS One. 2011;6(12):e28563<br/>[4]Ketene AN, et al. Actin filaments play a primary role for structural integrity and viscoelastic response in cells. Integr Biol (Camb). 2012 May;4(5):540-9.<br/>[5]Kozyreva VK, et al. NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner. Mol Cancer Res. 2014 May;12(5):681-93.<br/>[6]Brijmohan, Angela, et al. Role of HDAC6 in Transcription Factor EB Mediated Clearance of Misfolded Proteins in Chronic Kidney Disease. University of Toronto.Nov-2017.<br/>[7]Lechner S, Malgapo MIP, Grätz C, et al. Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target [published online ahead of print, 2022 Apr 28]. Nat Chem Biol. 2022;10.1038/s41589-022-01015-5. <br/>[8]Géraldy M, Morgen M, Sehr P, et al. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated. J Med Chem. 2019;62(9):4426-4443.<br/>[9]Severin Lechner, et al. Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. Nat Chem Biol. 2022 Apr 28. |
Smiles |
O=C(NO)C1=CC=C(CN2C3=C(CN(C)CC3)C4=C2C=CC=C4)C=C1 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
1252003-15-8 |
Lieferbar |
|
Product Description |
Tubastatin A is a potent and selective HDAC6 inhibitor with an IC50 of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A also inhibits HDAC10 and metallo-β-lactamase domain-containing protein 2 (MBLAC2). |
StorageTemperature |
-20°C, 3 years; 4°C, 2 years (Powder) |
Shipping |
Room Temperature |
Manufacturers Applications |
Cancer-programmed cell death |
MolecularWeight |
335.40 |
Clinical Information |
No Development Reported |
Manufacturers Research Area |
Cancer |
Solubility |
DMSO : 12.5 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL |
Target |
Apoptosis; Autophagy; Beta-lactamase; HDAC |
Manufacturers Target |
Apoptosis; Autophagy; Beta-lactamase; HDAC |
Isoform |
HDAC1; HDAC6; HDAC8 |
Manufacturers Pathway |
Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics |
Manufacturers Product type |
Reference compound |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.